Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-26-028948
Filing Date
2026-04-30
Accepted
2026-04-30 16:37:36
Documents
34
Period of Report
2026-06-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A allo-20260430.htm   iXBRL DEF 14A 914220
6 allo-20260430_g1.gif GRAPHIC 345180
7 allo-20260430_g10.jpg GRAPHIC 51652
8 allo-20260430_g11.jpg GRAPHIC 61106
9 allo-20260430_g12.jpg GRAPHIC 49947
10 allo-20260430_g13.jpg GRAPHIC 47207
11 allo-20260430_g14.jpg GRAPHIC 49038
12 allo-20260430_g15.jpg GRAPHIC 133668
13 allo-20260430_g16.jpg GRAPHIC 31650
14 allo-20260430_g17.jpg GRAPHIC 32775
15 allo-20260430_g18.jpg GRAPHIC 449480
16 allo-20260430_g19.jpg GRAPHIC 184919
17 allo-20260430_g2.jpg GRAPHIC 98131
18 allo-20260430_g3.jpg GRAPHIC 10381
19 allo-20260430_g4.jpg GRAPHIC 6416
20 allo-20260430_g5.jpg GRAPHIC 57864
21 allo-20260430_g6.jpg GRAPHIC 59601
22 allo-20260430_g7.jpg GRAPHIC 66011
23 allo-20260430_g8.jpg GRAPHIC 55451
24 allo-20260430_g9.jpg GRAPHIC 64703
  Complete submission text file 0001628280-26-028948.txt   6199265

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20260430.xsd EX-101.SCH 2611
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20260430_def.xml EX-101.DEF 2998
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20260430_lab.xml EX-101.LAB 3369
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20260430_pre.xml EX-101.PRE 2074
37 EXTRACTED XBRL INSTANCE DOCUMENT allo-20260430_htm.xml XML 81450
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38693 | Film No.: 26926348
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)